{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T08:39:50Z","timestamp":1763973590466,"version":"3.45.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97623","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T08:37:15Z","timestamp":1763973435000},"source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the Association Between Novel Lipid Biomarkers and Metabolic Syndrome: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Bijoya","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardik N","family":"Mahant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanta","family":"Chatterjee Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Nagda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikunj","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti KG","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, et al.. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120:1640-5. 10.1161\/CIRCULATIONAHA.109.192644","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1089\/met.2009.0024","article-title":"The metabolic syndrome in South Asians: epidemiology, determinants, and prevention","volume":"7","author":"Misra A","year":"2009","unstructured":"Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009, 7:497-514. 10.1089\/met.2009.0024","journal-title":"Metab Syndr Relat Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo S","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, et al.. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010, 56:1113-32. 10.1016\/j.jacc.2010.05.034","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"Reaven GM","year":"2011","unstructured":"Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am. 2011, 95:875-92. 10.1016\/j.mcna.2011.06.002","journal-title":"Med Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman AD","year":"2011","unstructured":"Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011, 4:337-45. 10.1161\/CIRCOUTCOMES.110.959247","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.06.057","article-title":"Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: the very large database of lipids-4 (VLDL-4) study","volume":"242","author":"Quispe R","year":"2015","unstructured":"Quispe R, Manalac RJ, Faridi KF, et al.. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: the very large database of lipids-4 (VLDL-4) study. Atherosclerosis. 2015, 242:243-50. 10.1016\/j.atherosclerosis.2015.06.057","journal-title":"Atherosclerosis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study","volume":"358","author":"Walldius G","year":"2001","unstructured":"Walldius G, Jungner I, Holme I, et al.. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001, 358:2026-33. 10.1016\/S0140-6736(01)07098-2","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera AV","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M, et al.. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011, 364:127-35. 10.1056\/NEJMoa1001689","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas S","year":"2017","unstructured":"Tsimikas S. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol. 2017, 69:692-711. 10.1016\/j.jacc.2016.11.042","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48120-5","article-title":"Novel and traditional lipid profiles in metabolic syndrome reveal a high atherogenicity","volume":"9","author":"Paredes S","year":"2019","unstructured":"Paredes S, Fonseca L, Ribeiro L, Ramos H, Oliveira JC, Palma I. Novel and traditional lipid profiles in metabolic syndrome reveal a high atherogenicity. Sci Rep. 2019, 9:11792. 10.1038\/s41598-019-48120-5","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2019-0366","article-title":"Novel cardiovascular risk biomarkers in metabolic syndrome","volume":"13","author":"Montecucco F","year":"2019","unstructured":"Montecucco F, Liberale L, Carbone F. Novel cardiovascular risk biomarkers in metabolic syndrome. Biomark Med. 2019, 13:1331-4. 10.2217\/bmm-2019-0366","journal-title":"Biomark Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence","volume":"259","author":"Walldius G","year":"2006","unstructured":"Walldius G, Jungner I. The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med. 2006, 259:493-519. 10.1111\/j.1365-2796.2006.01643.x","journal-title":"J Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.658","article-title":"Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34)","volume":"23","author":"Deepa M","year":"2007","unstructured":"Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007, 23:127-34. 10.1002\/dmrr.658","journal-title":"Diabetes Metab Res Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae032","article-title":"Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research","volume":"31","author":"Kamstrup PR","year":"2024","unstructured":"Kamstrup PR, Neely RD, Nissen S, et al.. Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research. Eur J Prev Cardiol. 2024, 31:903-14. 10.1093\/eurjpc\/zwae032","journal-title":"Eur J Prev Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter P","year":"2007","unstructured":"Barter P, Gotto AM, LaRosa JC, et al.. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007, 357:1301-10. 10.1056\/NEJMoa064278","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.13800","article-title":"Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population","volume":"13","author":"Srikanthan K","year":"2016","unstructured":"Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016, 13:25-38. 10.7150\/ijms.13800","journal-title":"Int J Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra A","year":"2008","unstructured":"Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93:S9-30. 10.1210\/jc.2008-1595","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415677-unraveling-the-association-between-novel-lipid-biomarkers-and-metabolic-syndrome-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T08:37:16Z","timestamp":1763973436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415677-unraveling-the-association-between-novel-lipid-biomarkers-and-metabolic-syndrome-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.97623","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}